Abstract
M channels, an important regulator of neural excitability, are composed of four subunits of the Kv7 (KCNQ) K+ channel family. M channels were named as such because their activity was suppressed by stimulation of muscarinic acetylcholine receptors. These channels are of particular interest because they are activated at the subthreshold membrane potentials. Furthermore, neural KCNQ channels are drug targets for the treatments of epilepsy and a variety of neurological disorders, including chronic and neuropathic pain, deafness, and mental illness. This review will update readers on the roles of KCNQ channels in the sensory system and neural circuits as well as discuss their respective mechanisms and the implications for physiology and medicine. We will also consider future perspectives and the development of additional pharmacological models, such as seizure, stroke, pain and mental illness, which work in combination with drug-design targeting of KCNQ channels. These models will hopefully deepen our understanding of KCNQ channels and provide general therapeutic prospects of related channelopathies.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Brown DA, Adams PR . Muscarinic suppression of a novel voltage-sensitive K+ current in a vertebrate neurone. Nature 1980; 283: 673–6.
Delmas P, Brown DA . Pathways modulating neural KCNQ/M (Kv7) potassium channels. Nat Rev Neurosci 2005; 6: 850–62.
Tyson J, Tranebjaerg L, McEntagart M, Larsen LA, Christiansen M, Whiteford ML, et al. Mutational spectrum in the cardioauditory syndrome of Jervell and Lange-Nielsen. Hum Genet 2000; 107: 499–503.
Robbins J . KCNQ potassium channels: physiology, pathophysiology, and pharmacology. Pharmacol Ther 2001; 90: 1–19.
Wang HS, Pan Z, Shi W, Brown BS, Wymore RS, Cohen IS, et al. KCNQ2 and KCNQ3 potassium channel subunits: molecular correlates of the M-channel. Science 1998; 282: 1890–3.
Biervert C, Schroeder BC, Kubisch C, Berkovic SF, Propping P, Jentsch TJ, et al. A potassium channel mutation in neonatal human epilepsy. Science 1998; 279: 403–6.
Charlier C, Singh NA, Ryan SG, Lewis TB, Reus BE, Leach RJ, et al. A pore mutation in a novel KQT-like potassium channel gene in an idiopathic epilepsy family. Nat Genet 1998; 18: 53–5.
Kharkovets T, Hardelin JP, Safieddine S, Schweizer M, El-Amraoui A, Petit C, et al. KCNQ4, a K+ channel mutated in a form of dominant deafness, is expressed in the inner ear and the central auditory pathway. Proc Natl Acad Sci U S A 2000; 97: 4333–8.
Heidenreich M, Lechner SG, Vardanyan V, Wetzel C, Cremers CW, De Leenheer EM, et al. KCNQ4 K+ channels tune mechanoreceptors for normal touch sensation in mouse and man. Nat Neurosci 2012; 15: 138–45.
Smith JS, Iannotti CA, Dargis P, Christian EP, Aiyar J . Differential expression of kcnq2 splice variants: implications to m current function during neuronal development. J Neurosci 2001; 21: 1096–103.
Huang H, Trussell LO . KCNQ5 channels control resting properties and release probability of a synapse. Nat Neurosci 2011; 14: 840–7.
Wang M, Gamo NJ, Yang Y, Jin LE, Wang XJ, Laubach M, et al. Neuronal basis of age-related working memory decline. Nature 2011; 476: 210–3.
Passmore GM, Selyanko AA, Mistry M, Al-Qatari M, Marsh SJ, Matthews EA, et al. KCNQ/M currents in sensory neurons: significance for pain therapy. J Neurosci 2003; 23: 7227–36.
Zhang H, Craciun LC, Mirshahi T, Rohacs T, Lopes CM, Jin T, et al. PIP(2) activates KCNQ channels, and its hydrolysis underlies receptor-mediated inhibition of M currents. Neuron 2003; 37: 963–75.
Li Y, Gamper N, Hilgemann DW, Shapiro MS . Regulation of Kv7 (KCNQ) K+ channel open probability by phosphatidylinositol 4,5-bisphosphate. J Neurosci 2005; 25: 9825–35.
Zaika O, Lara LS, Gamper N, Hilgemann DW, Jaffe DB, Shapiro MS . Angiotensin II regulates neuronal excitability via phosphatidylinositol 4,5-bisphosphate-dependent modulation of Kv7 (M-type) K+ channels. J Physiol 2006; 575: 49–67.
Bofill-Cardona E, Vartian N, Nanoff C, Freissmuth M, Boehm S . Two different signaling mechanisms involved in the excitation of rat sympathetic neurons by uridine nucleotides. Mol Pharmacol 2000; 57: 1165–72.
Delmas P, Wanaverbecq N, Abogadie FC, Mistry M, Brown DA . Signaling microdomains define the specificity of receptor-mediated InsP(3) pathways in neurons. Neuron 2002; 34: 209–20.
Zaika O, Tolstykh GP, Jaffe DB, Shapiro MS . Inositol triphosphate-mediated Ca2+ signals direct purinergic P2Y receptor regulation of neuronal ion channels. J Neurosci 2007; 27: 8914–26.
Gamper N, Shapiro MS . Calmodulin mediates Ca2+-dependent modulation of M-type K+ channels. J Gen Physiol 2003; 122: 17–31.
Gamper N, Li Y, Shapiro MS . Structural requirements for differential sensitivity of KCNQ K+ channels to modulation by Ca2+/calmodulin. Mol Biol Cell 2005; 16: 3538–51.
Gamper N, Shapiro MS . Regulation of ion transport proteins by membrane phosphoinositides. Nat Rev Neurosci 2007; 8: 921–34.
Gamper N, Shapiro MS . Target-specific PIP(2) signalling: how might it work? J Physiol 2007; 582: 967–75.
Lopes CM, Remon JI, Matavel A, Sui JL, Keselman I, Medei E, et al. Protein kinase A modulates PLC-dependent regulation and PIP2-sensitivity of K+ channels. Channels (Austin) 2007; 1: 124–34.
Wen H, Jurkovicova D, Pickel VM, Gioio AE, Kaplan BB . Identification of a novel membrane-associated protein expressed in neurons of the squid and rodent nervous systems. Neuroscience 2002; 114: 995–1004.
Hernandez CC, Zaika O, Tolstykh GP, Shapiro MS . Regulation of neural KCNQ channels: signalling pathways, structural motifs and functional implications. J Physiol 2008; 586: 1811–21.
Hoshi N, Zhang JS, Omaki M, Takeuchi T, Yokoyama S, Wanaverbecq N, et al. AKAP150 signaling complex promotes suppression of the M-current by muscarinic agonists. Nat Neurosci 2003; 6: 564–71.
Li Y, Langlais P, Gamper N, Liu F, Shapiro MS . Dual phosphorylations underlie modulation of unitary KCNQ K+ channels by Src tyrosine kinase. J Biol Chem 2004; 279: 45399–407.
Li Y, Gamper N, Shapiro MS . Single-channel analysis of KCNQ K+ channels reveals the mechanism of augmentation by a cysteine-modifying reagent. J Neurosci 2004; 24: 5079–90.
Zhang Q, Zhou P, Chen Z, Li M, Jiang H, Gao Z, et al. Dynamic PIP2 interactions with voltage sensor elements contribute to KCNQ2 channel gating. Proc Natl Acad Sci U S A 2013; 110: 20093–8.
Chen L, Zhang Q, Qiu Y, Li Z, Chen Z, Jiang H, et al. Migration of PIP2 lipids on voltage-gated potassium channel surface influences channel deactivation. Sci Rep 2015; 5: 15079.
Zhang J, Shapiro MS . Activity-dependent transcriptional regulation of M-Type (Kv7) K+ channels by AKAP79/150-mediated NFAT actions. Neuron 2012; 76: 1133–46.
Storm JF . Action potential repolarization and a fast after-hyperpolarization in rat hippocampal pyramidal cells. J Physiol 1987; 385: 733–59.
Williams SR, Stuart GJ . Mechanisms and consequences of action potential burst firing in rat neocortical pyramidal neurons. J Physiol 1999; 521 Pt 2: 467–82.
Bean BP . The action potential in mammalian central neurons. Nat Rev Neurosci 2007; 8: 451–65.
Piccinin S, Randall AD, Brown JT . KCNQ/Kv7 channel regulation of hippocampal gamma-frequency firing in the absence of synaptic transmission. J Neurophysiol 2006; 95: 3105–12.
Brown DA, Passmore GM . Neural KCNQ (Kv7) channels. Br J Pharmacol 2009; 156: 1185–95.
Peters HC, Hu H, Pongs O, Storm JF, Isbrandt D . Conditional transgenic suppression of M channels in mouse brain reveals functions in neuronal excitability, resonance and behavior. Nat Neurosci 2005; 8: 51–60.
Luebke JI, Chang YM . Effects of aging on the electrophysiological properties of layer 5 pyramidal cells in the monkey prefrontal cortex. Neuroscience 2007; 150: 556–62.
Goldman-Rakic PS . Cellular basis of working memory. Neuron 1995; 14: 477–85.
Dodson PD, Forsythe ID . Presynaptic K+ channels: electrifying regulators of synaptic terminal excitability. Trends Neurosci 2004; 27: 210–7.
Kim JH, Sizov I, Dobretsov M, von Gersdorff H . Presynaptic Ca2+ buffers control the strength of a fast post-tetanic hyperpolarization mediated by the alpha3 Na+/K+-ATPase. Nat Neurosci 2007; 10: 196–205.
Huang H, Trussell LO . Control of presynaptic function by a persistent Na+ current. Neuron 2008; 60: 975–9.
Gardiner M, Lehesjoki AE . Genetics of the epilepsies. Curr Opin Neurol 2000; 13: 157–64.
Ronen GM, Rosales TO, Connolly M, Anderson VE, Leppert M . Seizure characteristics in chromosome 20 benign familial neonatal convulsions. Neurology 1993; 43: 1355–60.
Singh NA, Charlier C, Stauffer D, DuPont BR, Leach RJ, Melis R, et al. A novel potassium channel gene, KCNQ2, is mutated in an inherited epilepsy of newborns. Nat Genet 1998; 18: 25–9.
Hirose S, Zenri F, Akiyoshi H, Fukuma G, Iwata H, Inoue T, et al. A novel mutation of KCNQ3 (c.925T-->C) in a Japanese family with benign familial neonatal convulsions. Ann Neurol 2000; 47: 822–6.
Schroeder BC, Kubisch C, Stein V, Jentsch TJ . Moderate loss of function of cyclic-AMP-modulated KCNQ2/KCNQ3 K+ channels causes epilepsy. Nature 1998; 396: 687–90.
Neyroud N, Tesson F, Denjoy I, Leibovici M, Donger C, Barhanin J, et al. A novel mutation in the potassium channel gene KVLQT1 causes the Jervell and Lange-Nielsen cardioauditory syndrome. Nat Genet 1997; 15: 186–9.
Schmitt N, Schwarz M, Peretz A, Abitbol I, Attali B, Pongs O . A recessive C-terminal Jervell and Lange-Nielsen mutation of the KCNQ1 channel impairs subunit assembly. EMBO J 2000; 19: 332–40.
Splawski I, Timothy KW, Vincent GM, Atkinson DL, Keating MT . Molecular basis of the long-QT syndrome associated with deafness. N Engl J Med 1997; 336: 1562–7.
Kubisch C, Schroeder BC, Friedrich T, Lutjohann B, El-Amraoui A, Marlin S, et al. KCNQ4, a novel potassium channel expressed in sensory outer hair cells, is mutated in dominant deafness. Cell 1999; 96: 437–46.
Kharkovets T, Dedek K, Maier H, Schweizer M, Khimich D, Nouvian R, et al. Mice with altered KCNQ4 K+ channels implicate sensory outer hair cells in human progressive deafness. EMBO J 2006; 25: 642–52.
Coucke PJ, Van Hauwe P, Kelley PM, Kunst H, Schatteman I, Van Velzen D, et al. Mutations in the KCNQ4 gene are responsible for autosomal dominant deafness in four DFNA2 families. Hum Mol Genet 1999; 8: 1321–8.
Kamada F, Kure S, Kudo T, Suzuki Y, Oshima T, Ichinohe A, et al. A novel KCNQ4 one-base deletion in a large pedigree with hearing loss: implication for the genotype-phenotype correlation. J Hum Genet 2006; 51: 455–60.
Jentsch TJ . Neuronal KCNQ potassium channels: physiology and role in disease. Nat Rev Neurosci 2000; 1: 21–30.
Talebizadeh Z, Kelley PM, Askew JW, Beisel KW, Smith SD . Novel mutation in the KCNQ4 gene in a large kindred with dominant progressive hearing loss. Hum Mutat 1999; 14: 493–501.
Akita J, Abe S, Shinkawa H, Kimberling WJ, Usami S . Clinical and genetic features of nonsyndromic autosomal dominant sensorineural hearing loss: KCNQ4 is a gene responsible in Japanese. J Hum Genet 2001; 46: 355–61.
Van Camp G, Coucke PJ, Akita J, Fransen E, Abe S, De Leenheer EM, et al. A mutational hot spot in the KCNQ4 gene responsible for autosomal dominant hearing impairment. Hum Mutat 2002; 20: 15–9.
Mencia A, Gonzalez-Nieto D, Modamio-Hoybjor S, Etxeberria A, Aranguez G, Salvador N, et al. A novel KCNQ4 pore-region mutation (p.G296S) causes deafness by impairing cell-surface channel expression. Hum Genet 2008; 123: 41–53.
Garcia-Pino E, Caminos E, Juiz JM . KCNQ5 reaches synaptic endings in the auditory brainstem at hearing onset and targeting maintenance is activity-dependent. J Comp Neurol 2010; 518: 1301–14.
Schroeder BC, Hechenberger M, Weinreich F, Kubisch C, Jentsch TJ . KCNQ5, a novel potassium channel broadly expressed in brain, mediates M-type currents. J Biol Chem 2000; 275: 24089–95.
Lerche C, Scherer CR, Seebohm G, Derst C, Wei AD, Busch AE, et al. Molecular cloning and functional expression of KCNQ5, a potassium channel subunit that may contribute to neuronal M-current diversity. J Biol Chem 2000; 275: 22395–400.
Trussell LO . Synaptic mechanisms for coding timing in auditory neurons. Annu Rev Physiol 1999; 61: 477–96.
Strauss O . The retinal pigment epithelium in visual function. Physiol Rev 2005; 85: 845–81.
Quinn RH, Miller SS . Ion transport mechanisms in native human retinal pigment epithelium. Invest Ophthalmol Vis Sci 1992; 33: 3513–27.
Zhang X, Yang D, Hughes BA . KCNQ5/K(v)7.5 potassium channel expression and subcellular localization in primate retinal pigment epithelium and neural retina. Am J Physiol Cell Physiol 2011; 301: C1017–26.
Pattnaik BR, Hughes BA . Effects of KCNQ channel modulators on the M-type potassium current in primate retinal pigment epithelium. Am J Physiol Cell Physiol 2012; 302: C821–33.
Wickenden AD, McNaughton-Smith G . Kv7 channels as targets for the treatment of pain. Curr Pharm Des 2009; 15: 1773–98.
Rigdon RO . Protocols for the prevention of intravascular device-related infections. Crit Care Nurs Q 2001; 24: 39–47.
Devaux JJ, Kleopa KA, Cooper EC, Scherer SS . KCNQ2 is a nodal K channel. J Neurosci 2004; 24: 1236–44.
Zheng Y, Xu H, Zhan L, Zhou X, Chen X, Gao Z . Activation of peripheral KCNQ channels relieves gout pain. Pain 2015; 156: 1025–35.
Rivera-Arconada I, Martinez-Gomez J, Lopez-Garcia JA . M-current modulators alter rat spinal nociceptive transmission: an electrophysiological study in vitro. Neuropharmacology 2004; 46: 598–606.
Dost R, Rostock A, Rundfeldt C . The anti-hyperalgesic activity of retigabine is mediated by KCNQ potassium channel activation. Naunyn Schmiedebergs Arch Pharmacol 2004; 369: 382–90.
Szelenyi I, Nickel B, Borbe HO, Brune K . Mode of antinociceptive action of flupirtine in the rat. Br J Pharmacol 1989; 97: 835–42.
Swedberg MD . The mouse grid-shock analgesia test: pharmacological characterization of latency to vocalization threshold as an index of antinociception. J Pharmacol Exp Ther 1994; 269: 1021–8.
Diamantis W, Gordon R, Sofia RD . Analgesic activity following combined oral administration of flupirtine maleate and peripherally acting analgesics in mice and rats. Postgrad Med J 1987; 63 Suppl 3: 29–34.
Luo M, Fee MS, Katz LC . Encoding pheromonal signals in the accessory olfactory bulb of behaving mice. Science 2003; 299: 1196–201.
Xu F, Schaefer M, Kida I, Schafer J, Liu N, Rothman DL, et al. Simultaneous activation of mouse main and accessory olfactory bulbs by odors or pheromones. J Comp Neurol 2005; 489: 491–500.
Hendrickson RC, Krauthamer S, Essenberg JM, Holy TE . Inhibition shapes sex selectivity in the mouse accessory olfactory bulb. J Neurosci 2008; 28: 12523–34.
Kaba H, Hayashi Y, Higuchi T, Nakanishi S . Induction of an olfactory memory by the activation of a metabotropic glutamate receptor. Science 1994; 265: 262–4.
Castillo PE, Carleton A, Vincent JD, Lledo PM . Multiple and opposing roles of cholinergic transmission in the main olfactory bulb. J Neurosci 1999; 19: 9180–91.
Ghatpande AS, Sivaraaman K, Vijayaraghavan S . Store calcium mediates cholinergic effects on mIPSCs in the rat main olfactory bulb. J Neurophysiol 2006; 95: 1345–55.
Takahashi Y, Kaba H . Muscarinic receptor type 1 (M1) stimulation, probably through KCNQ/Kv7 channel closure, increases spontaneous GABA release at the dendrodendritic synapse in the mouse accessory olfactory bulb. Brain Res 2010; 1339: 26–40.
Martire M, Castaldo P, D'Amico M, Preziosi P, Annunziato L, Taglialatela M . M channels containing KCNQ2 subunits modulate norepinephrine, aspartate, and GABA release from hippocampal nerve terminals. J Neurosci 2004; 24: 592–7.
Shinoe T, Matsui M, Taketo MM, Manabe T . Modulation of synaptic plasticity by physiological activation of M1 muscarinic acetylcholine receptors in the mouse hippocampus. J Neurosci 2005; 25: 11194–200.
Anagnostaras SG, Murphy GG, Hamilton SE, Mitchell SL, Rahnama NP, Nathanson NM, et al. Selective cognitive dysfunction in acetylcholine M1 muscarinic receptor mutant mice. Nat Neurosci 2003; 6: 51–8.
Wess J . Muscarinic acetylcholine receptor knockout mice: novel phenotypes and clinical implications. Annu Rev Pharmacol Toxicol 2004; 44: 423–50.
Seol GH, Ziburkus J, Huang S, Song L, Kim IT, Takamiya K, et al. Neuromodulators control the polarity of spike-timing-dependent synaptic plasticity. Neuron 2007; 55: 919–29.
Boddeke EW, Enz A, Shapiro G . SDZ ENS 163, a selective muscarinic M1 receptor agonist, facilitates the induction of long-term potentiation in rat hippocampal slices. Eur J Pharmacol 1992; 222: 21–5.
Buchanan KA, Petrovic MM, Chamberlain SE, Marrion NV, Mellor JR . Facilitation of long-term potentiation by muscarinic M(1) receptors is mediated by inhibition of SK channels. Neuron 2010; 68: 948–63.
Dean B, Bymaster FP, Scarr E . Muscarinic receptors in schizophrenia. Curr Mol Med 2003; 3: 419–26.
Giessel AJ, Sabatini BL . M1 muscarinic receptors boost synaptic potentials and calcium influx in dendritic spines by inhibiting postsynaptic SK channels. Neuron 2010; 68: 936–47.
Madison DV, Lancaster B, Nicoll RA . Voltage clamp analysis of cholinergic action in the hippocampus. J Neurosci 1987; 7: 733–41.
Marrion NV, Smart TG, Marsh SJ, Brown DA . Muscarinic suppression of the M-current in the rat sympathetic ganglion is mediated by receptors of the M1-subtype. Br J Pharmacol 1989; 98: 557–73.
Ngo-Anh TJ, Bloodgood BL, Lin M, Sabatini BL, Maylie J, Adelman JP . SK channels and NMDA receptors form a Ca2+-mediated feedback loop in dendritic spines. Nat Neurosci 2005; 8: 642–9.
Fontan-Lozano A, Suarez-Pereira I, Delgado-Garcia JM, Carrion AM . The M-current inhibitor XE991 decreases the stimulation threshold for long-term synaptic plasticity in healthy mice and in models of cognitive disease. Hippocampus 2011; 21: 22–32.
Lampe BJ, Gaskill JL, Keim SC, Brown BS . Linopirdine reduces stimulus intensity threshold for induction of long-term potentiation in the Schaffer collateral/CA1 pathway in rat hippocampal slices. Neurosci Lett 1997; 222: 135–7.
Brown JT, Randall AD . Activity-dependent depression of the spike after-depolarization generates long-lasting intrinsic plasticity in hippocampal CA3 pyramidal neurons. J Physiol 2009; 587: 1265–81.
Grunnet M, Strobaek D, Hougaard C, Christophersen P . Kv7 channels as targets for anti-epileptic and psychiatric drug-development. Eur J Pharmacol 2014; 726: 133–7.
Acknowledgements
This work was supported in part by the National Natural Science Foundation (31128009, 31171011, 31171066 and 91413122) and the Ministry of Science and Technology (2013CB910601).
Author information
Authors and Affiliations
Corresponding author
PowerPoint slides
Rights and permissions
About this article
Cite this article
Wang, Jj., Li, Y. KCNQ potassium channels in sensory system and neural circuits. Acta Pharmacol Sin 37, 25–33 (2016). https://doi.org/10.1038/aps.2015.131
Received:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/aps.2015.131
Keywords
This article is cited by
-
Epilepsy and brain channelopathies from infancy to adulthood
Neurological Sciences (2020)
-
Dynamic interplay between H-current and M-current controls motoneuron hyperexcitability in amyotrophic lateral sclerosis
Cell Death & Disease (2019)
-
Ion channels research in the post-genomic era
Acta Pharmacologica Sinica (2016)
